• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 438267 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1413985108 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1413985108 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Highest Sales per Share in the Biotechnology Industry Detected for Biogen Idec (BIIB, AMGN, UTHR)

Published on Thu, 02/07/2013 - 11:25
By Robert Cotter

Below are the three companies in the Biotechnology industry with the highest sales per share. Sales per share is a valuable metric in comparing relative value for companies in the same industry.

Biogen Idec (NASDAQ:BIIB) is highest with sales per share of $23.19. Biogen Idec Inc. develops, manufactures, and commercializes therapies, focusing on neurology, oncology, and immunology. The Company's products addresses diseases such as multiple sclerosis, non-Hodgkin's lymphoma, rheumatoid arthritis, crohn's disease, and psoriasis.

Biogen Idec (NASDAQ:BIIB) is currently priced 0.7% above its average consensus analyst price target of $159.90. The stock should discover initial support at its 50-day moving average (MA) of $149.44 and subsequent support at its 200-day MA of $144.14.

Amgen (NASDAQ:AMGN) is next with sales per share of $22.28.

Finishing up the top three is United Therapeutics (NASDAQ:UTHR), with sales per share of $16.38.

By Robert Cotter
rcotter@fnno.com

Latest News from FNNO

Analyst Rating In Review: Teva Pharmaceu...

Teva Pharmaceutical Industries was upgraded from Hold to Buy by Standpoint Research one ...

Avis Budget Group has the Best Relative ...

Here are the top 5 stocks in the Trucking industry ranked by performance. We compiled ...

Shares of AK Steel Holding Rank the High...

We looked at the Steel industry and measured relative performance to find the top stock ...

Relatively Good Performance Detected in ...

We looked at the Specialty Chemicals industry and measured relative performance to find ...

Relatively Good Performance Detected in ...

We looked at the Semiconductors industry and measured relative performance to find the ...

Shares of Amkor Technology Rank the High...

We looked at the Semiconductor Equipment industry and measured relative performance to ...

Shares of Reinsurance Group of America R...

Here are the top 5 stocks in the Reinsurance industry ranked by performance. We compil ...

Best Relative Performance in the Regiona...

We looked at the Regional Banks industry and measured relative performance to find the ...